HUP9904608A3 - Process for producing n-(amino-4,6-dihalogeno-pyrimidin)-formamide derivatives - Google Patents

Process for producing n-(amino-4,6-dihalogeno-pyrimidin)-formamide derivatives

Info

Publication number
HUP9904608A3
HUP9904608A3 HU9904608A HUP9904608A HUP9904608A3 HU P9904608 A3 HUP9904608 A3 HU P9904608A3 HU 9904608 A HU9904608 A HU 9904608A HU P9904608 A HUP9904608 A HU P9904608A HU P9904608 A3 HUP9904608 A3 HU P9904608A3
Authority
HU
Hungary
Prior art keywords
dihalogeno
pyrimidin
amino
producing
formamide derivatives
Prior art date
Application number
HU9904608A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Lonza Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza Ag filed Critical Lonza Ag
Publication of HU9904608D0 publication Critical patent/HU9904608D0/hu
Publication of HUP9904608A2 publication Critical patent/HUP9904608A2/hu
Publication of HUP9904608A3 publication Critical patent/HUP9904608A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
HU9904608A 1998-12-21 1999-12-16 Process for producing n-(amino-4,6-dihalogeno-pyrimidin)-formamide derivatives HUP9904608A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP98124188 1998-12-21
EP99100788 1999-01-18
EP99107161 1999-04-12
US14610699P 1999-07-29 1999-07-29

Publications (3)

Publication Number Publication Date
HU9904608D0 HU9904608D0 (en) 2000-03-28
HUP9904608A2 HUP9904608A2 (hu) 2000-08-28
HUP9904608A3 true HUP9904608A3 (en) 2001-03-28

Family

ID=27443679

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9904608A HUP9904608A3 (en) 1998-12-21 1999-12-16 Process for producing n-(amino-4,6-dihalogeno-pyrimidin)-formamide derivatives

Country Status (16)

Country Link
US (2) US6271376B1 (fr)
EP (2) EP1188750B1 (fr)
JP (1) JP3543709B2 (fr)
KR (1) KR100645270B1 (fr)
CN (1) CN1156449C (fr)
AT (2) ATE228508T1 (fr)
CA (1) CA2293011C (fr)
CZ (2) CZ296753B6 (fr)
DE (2) DE59907401D1 (fr)
DK (1) DK1013647T3 (fr)
ES (2) ES2204798T3 (fr)
HU (1) HUP9904608A3 (fr)
NO (1) NO313878B1 (fr)
PL (1) PL337354A1 (fr)
PT (1) PT1013647E (fr)
SK (2) SK283681B6 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208011B2 (en) * 2001-08-20 2007-04-24 Conor Medsystems, Inc. Implantable medical device with drug filled holes
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7208010B2 (en) * 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
GB2344550A (en) * 1998-12-09 2000-06-14 Ibm Pad design for electronic package
EP1582180B1 (fr) 2000-10-16 2008-02-27 Conor Medsystems, Inc. Dispositif médical extensible pour delivrance d'un médicament
US20040204756A1 (en) * 2004-02-11 2004-10-14 Diaz Stephen Hunter Absorbent article with improved liquid acquisition capacity
US7056338B2 (en) * 2003-03-28 2006-06-06 Conor Medsystems, Inc. Therapeutic agent delivery device with controlled therapeutic agent release rates
US20040249443A1 (en) * 2001-08-20 2004-12-09 Shanley John F. Expandable medical device for treating cardiac arrhythmias
AU2003234670B2 (en) * 2002-05-24 2010-06-10 Angiotech International Ag Compositions and methods for coating medical implants
US20040142014A1 (en) * 2002-11-08 2004-07-22 Conor Medsystems, Inc. Method and apparatus for reducing tissue damage after ischemic injury
KR20130032407A (ko) * 2002-11-08 2013-04-01 코너 메드시스템즈, 엘엘씨 허혈성 상해 후에 조직 손상을 감소시키기 위한 방법 및 장치
JP2006505364A (ja) * 2002-11-08 2006-02-16 コナー　メドシステムズ，　インコーポレイテッド 血管新生因子の局所供給を用いる、慢性全梗塞を処置するための拡張可能な医療装置および方法
FR2849030A1 (fr) * 2002-12-20 2004-06-25 Isochem Sa Procede de preparation des n-(2-amino-4, 6-dihalogenopyrimidin-5-yl) formamides
US20040202692A1 (en) * 2003-03-28 2004-10-14 Conor Medsystems, Inc. Implantable medical device and method for in situ selective modulation of agent delivery
EP1610823B1 (fr) 2003-03-28 2011-09-28 Innovational Holdings, LLC Dispositif medical implantable a gradient de concentration d'agent continuel
US20050010170A1 (en) * 2004-02-11 2005-01-13 Shanley John F Implantable medical device with beneficial agent concentration gradient
WO2004103979A1 (fr) * 2003-05-26 2004-12-02 Sumitomo Chemical Company, Limited Procede de production de n-(2-amino-4,6-dichloropyrimidine-5-yl)formamide
US7208596B2 (en) * 2003-11-25 2007-04-24 Bristol-Myers Squibb Pharma Company Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof
US20050287287A1 (en) * 2004-06-24 2005-12-29 Parker Theodore L Methods and systems for loading an implantable medical device with beneficial agent
CN101003511B (zh) * 2007-01-19 2010-06-09 中国科学院上海有机化学研究所 制备2-氨基-4,6-二氯-5-甲酰氨基嘧啶的方法
CZ305457B6 (cs) 2011-02-28 2015-09-30 Ústav organické chemie a biochemie, Akademie věd ČR v. v. i. Pyrimidinové sloučeniny inhibující tvorbu oxidu dusnatého a prostaglandinu E2, způsob výroby a použití
WO2014023681A1 (fr) * 2012-08-06 2014-02-13 Enantia, S.L. Procédé pour la préparation d'un intermédiaire pour un carbonucléoside de triazolopyrimidine
CN103936681B (zh) * 2014-04-04 2015-07-29 苏州开元民生科技股份有限公司 2-氨基-4,6-二氯-5-甲酰胺基嘧啶的制备方法
CN115536595B (zh) * 2022-11-29 2023-03-10 苏州开元民生科技股份有限公司 一种2-氨基-4,6-二氯-5-甲酰胺基嘧啶的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3445293A1 (de) * 1984-12-12 1986-06-12 Bayer Ag, 5090 Leverkusen Neue 2,4-diaminopyrimidine
US4965270A (en) * 1987-05-30 1990-10-23 Beecham Group P.L.C. Purine derivatives
CN1019575B (zh) * 1988-02-19 1992-12-23 石原产业株式会社 2-氨基-4，6-二氯嘧啶的生产方法
DE3900471A1 (de) * 1989-01-10 1990-07-12 Basf Ag Verfahren zur herstellung von 2-amino-4-fluorpyrimidinderivaten
GB8916698D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Novel process
SK279618B6 (sk) * 1992-01-22 1999-01-11 Lonza A.G. (Dir.:Basel) N-5-chránené 2,5-diamino-4,6-dichlórpyrimidíny a s
GB9402161D0 (en) * 1994-02-04 1994-03-30 Wellcome Found Chloropyrimidine intermediates
CA2145928C (fr) * 1994-04-27 2007-10-09 Gerhard Stucky N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide; methode de preparation
AT402924B (de) * 1994-05-13 1997-09-25 Chemie Linz Gmbh Verfahren zur herstellung von 2-amino-4,6-dichloro-pyrimidin

Also Published As

Publication number Publication date
EP1013647A3 (fr) 2000-10-04
ES2187112T3 (es) 2003-05-16
JP2000191647A (ja) 2000-07-11
CZ9904598A3 (cs) 2001-03-14
JP3543709B2 (ja) 2004-07-21
CZ296832B6 (cs) 2006-06-14
SK178499A3 (en) 2000-09-12
EP1013647A2 (fr) 2000-06-28
US6271376B1 (en) 2001-08-07
DK1013647T3 (da) 2003-03-10
CN1265393A (zh) 2000-09-06
EP1013647B1 (fr) 2002-11-27
EP1188750A1 (fr) 2002-03-20
US6716981B2 (en) 2004-04-06
DE59907401D1 (de) 2003-11-20
EP1188750B1 (fr) 2003-10-15
CZ296753B6 (cs) 2006-06-14
US20010031868A1 (en) 2001-10-18
PT1013647E (pt) 2003-04-30
SK285222B6 (sk) 2006-09-07
HU9904608D0 (en) 2000-03-28
NO996325D0 (no) 1999-12-20
CN1156449C (zh) 2004-07-07
KR20000052540A (ko) 2000-08-25
DE59903535D1 (de) 2003-01-09
ATE228508T1 (de) 2002-12-15
HUP9904608A2 (hu) 2000-08-28
PL337354A1 (en) 2000-07-03
ATE252087T1 (de) 2003-11-15
CA2293011A1 (fr) 2000-06-21
ES2204798T3 (es) 2004-05-01
KR100645270B1 (ko) 2006-11-13
SK283681B6 (sk) 2003-11-04
NO313878B1 (no) 2002-12-16
CA2293011C (fr) 2004-08-10
NO996325L (no) 2000-06-22

Similar Documents

Publication Publication Date Title
HUP9904608A3 (en) Process for producing n-(amino-4,6-dihalogeno-pyrimidin)-formamide derivatives
HK1046681A1 (en) 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use
HUP0101192A3 (en) Cycloalkene derivatives, process for producing the same, and use
HUP0101375A3 (en) Novel cephalotaxane derivatives, process for their preparation and intermediates
SG102603A1 (en) Method for making 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline
HUP0103659A3 (en) Process for producing 6-cyanomethyl-1,3-dioxane-4-acetic acid derivatives
PL348858A1 (en) Method for producing l-phenylephrine hydrochloride
HK1042473A1 (zh) 生產鹽衍生物的方法、和新的鹽衍生物
HUP0004884A3 (en) Process for preparing 1,4-dihydropyridine derivatives
AU6123099A (en) Process for the preparation of amine derivatives
IL142285A0 (en) Process for preparing phenoxazine derivatives
HUP0200144A3 (en) Process for preparing pesticidal 5-amino-1-aryl-3 cyanopyrazole derivatives, and the new intermediates
HUP0104067A3 (en) New processes for producing betha-alanine derivative
HUP9901041A3 (en) Process for preparing hydroxamic acid derivatives
EP1158043A4 (fr) Procede de production de l-lysine
HUP0102096A3 (en) Processes for preparing 1-cyclopropyl-5-phenyl-pentane-2,4-dion derivatives and their intermediates, and the new intermediates
IL145791A0 (en) Process for preparing mkc-442
IL146573A0 (en) Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones
PL343629A1 (en) Improved process for the manufacture of n-(1-cyanoalkyl)-2-phenoxypropionamide derivatives
IL146810A0 (en) Process for preparing 10, 11-methanobenzosuberane derivatives
HU9802105D0 (en) Process for producing 2,3,4,5-tetrafluorbenzene derivatives
HK1023559A1 (en) Process for producing dichloroacetoxypropane and derivatives thereof
HUP0004469A3 (en) Process for producing trifluormethyl-aniline derivatives
EG21526A (en) Improved process for preparing pharmaceutically useful norbenzomorphane derivatives
HUP0101063A3 (en) Process for preparing alkoxytriazolinone derivatives

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees